A prospective, randomized study.
A tertiary teaching and research hospital.
Two hundred eighty-eight patients who were undergoing intracytoplasmic sperm injection with a long protocol of controlled ovarian hyperstimulation.
Group 1 (E2 + P) received daily P plus 4 mg of E2, group 2 (hCG + P) received P plus 1,500 IU of hCG, and group 3 (P only) received daily vaginal P gel. Blood samples were drawn on the day of hCG administration, as well as 7 and 10 days after the hCG for the E2 and P measurements.
The clinical pregnancy rate.
No difference existed between the E2 + P and hCG + P groups with respect to pregnancy rate, but it was significantly lower in the P-only group.The implantation rate was significantly lower in the P-only group than in the other groups.The highest miscarriage rate was in the P-only group (38 % ).
In assisted reproductive technology cycles including treatment with GnRH agonist, adding 4 mg of oral E2 to P during the luteal phase significantly increased the pregnancy and implantation rates and decreased the miscarriage rate compared with the use of P only.